OTC · Healthcare
CapForce Inc. (CFOR)
As-reported financials and recent SEC filings for CapForce Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$30.2M
Net income
$23.6M
Net margin
78.2%
Diluted EPS
$2.32
ROE
74.1%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $30.2M | $5.2M | $3.4M | $2.6M | $4.3M |
| Gross profit | — | — | $334,245 | $-712,293 | $2.0M |
| Operating income | $24.0M | $324,717 | $-30.7M | $-34.6M | $-23.3M |
| Net income | $23.6M | $12.0M | $-32.7M | $-37.3M | $-34.8M |
| Diluted EPS | $2.32 | $1.15 | $-2.96 | $-3.64 | $-4.36 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →10-Q2026-06-12
View on EDGAR →10-K2026-05-26
View on EDGAR →Largest Healthcare peers
Go deeper on CFOR
Search CapForce Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.